ArticleJournal of managed care & specialty pharmacy2024

Cost burden of cirrhosis and liver disease progression in metabolic dysfunction-associated steatohepatitis: A US cohort study.

J Collin Fishman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.